Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 [1,2,3], and is a histologically and prognostically heterogeneous disease [4,5,6]. Here, PGR is linked to triple-negative breast carcinoma.